ArticleIn vivo (Athens, Greece)

Impact of C-reactive Protein Flare Response in Patients With Advanced Urothelial Carcinoma Who Received Pembrolizumab.

Ikko Tomisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.